Abcam
Last updated: .
What was reported
Abcam reported on 20 March 2023 that its London AIM listing ended on 14 December 2022 and Nasdaq became its sole public trading venue. The linked coverage runs from 17 October 2022 to 6 December 2023, with the record marked confirmed.
Background
According to Abcam's December 2022 update, the change concerned cancellation of its AIM listing. Abcam (via PR Newswire), 12 December 2022. The update said Abcam would retain its Nasdaq listing. Abcam (via PR Newswire), 12 December 2022. The same update identified Cambridge, UK as the company's headquarters. Abcam (via PR Newswire), 12 December 2022.
Timeline
Report dates show when a source published its account. Event dates keep the precision given by that source.
-
(Event): According to Abcam's December 2022 update, the company first announced its AIM cancellation proposal on this date. Abcam (via PR Newswire), 12 December 2022.
-
(Report): According to Abcam's update, the planned last AIM trading day was 13 December, followed by cancellation the next morning. Abcam (via PR Newswire), 12 December 2022.
-
(Event): According to the AIM cancellation notice, Abcam's ordinary shares ceased admission to AIM trading on this date. AIM notice via London South East, 14 December 2022.
- Type
- Company
- Known for
- Life science research tools supplier
- Recorded change
- United States
Sole Nasdaq listing from 14 December 2022; trading suspended on 6 December 2023 after acquisition by Danaher. - Status
- Confirmed
- Basis
- Read the source account above
- First reported
- 17 October 2022
- Sector
- Science and technology (Life science research tools)
- Last checked
- 25 October 2026
Recorded statement
No direct statement of a reason is recorded.
Wealth estimate
No sourced estimate is recorded.
Limits and uncertainty
This was a listing change. Abcam kept its headquarters in Cambridge and later ceased public trading after its acquisition.
Latest status check: 6 December 2023. Danaher confirmed its acquisition of Abcam on 6 December 2023 and the suspension of Nasdaq trading. This record covers the completed London listing cancellation in December 2022; Abcam kept its headquarters in Cambridge.
Sources
- Abcam, Primary source.
- Abcam (via Nasdaq), Primary source.
- Abcam (via PR Newswire), Primary source.
- Danaher, Primary source.
- AIM notice via London South East, Primary source.
- interactive investor, Secondary source.
Related
Similar company events
- Wise Group plc: Confirmed
- Ashtead Group plc (now Sunbelt Rentals Holdings): Confirmed
- Indivior Pharmaceuticals, Inc.: Confirmed
- BHP Group Limited (formerly dual-listed with BHP Group plc): Confirmed
Send a correction or right of reply. Read the public corrections log.